These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21792513)

  • 61. Segregation of signaling proteins as prognostic predictors for local recurrence and distant metastasis in hepatocellular carcinoma.
    Yeh CT; Huang YH; Liang KH; Chang ML; Hsu CW; Chen YC; Chen TC; Yeh TS; Lee WC
    Int J Oncol; 2014 Feb; 44(2):491-504. PubMed ID: 24297625
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor.
    Zhuang PY; Zhang JB; Zhu XD; Zhang W; Wu WZ; Tan YS; Hou J; Tang ZY; Qin LX; Sun HC
    Cancer; 2008 Jun; 112(12):2740-8. PubMed ID: 18412155
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumor-associated lymphangiogenesis correlates with prognosis after resection of human hepatocellular carcinoma.
    Thelen A; Jonas S; Benckert C; Weichert W; Schott E; Bötcher C; Dietz E; Wiedenmann B; Neuhaus P; Scholz A
    Ann Surg Oncol; 2009 May; 16(5):1222-30. PubMed ID: 19224279
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Significance of the expression of lymphocytes and cytokines infiltrating in HCC].
    Ye YB; Peng F; Li JY; Lin LP; Zheng XW; Zhou D; Li C; Li QL; Cai XW
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Oct; 27(10):1056-60. PubMed ID: 21968301
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma.
    Fu J; Zhang Z; Zhou L; Qi Z; Xing S; Lv J; Shi J; Fu B; Liu Z; Zhang JY; Jin L; Zhao Y; Lau GK; Zhao J; Wang FS
    Hepatology; 2013 Jul; 58(1):139-49. PubMed ID: 22961630
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma.
    Grabenbauer GG; Lahmer G; Distel L; Niedobitek G
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3355-60. PubMed ID: 16740757
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response.
    Oshikiri T; Miyamoto M; Shichinohe T; Suzuoki M; Hiraoka K; Nakakubo Y; Shinohara T; Itoh T; Kondo S; Katoh H
    J Surg Oncol; 2003 Dec; 84(4):224-8. PubMed ID: 14756433
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dendritic cell infiltration and prognosis of human hepatocellular carcinoma.
    Cai XY; Gao Q; Qiu SJ; Ye SL; Wu ZQ; Fan J; Tang ZY
    J Cancer Res Clin Oncol; 2006 May; 132(5):293-301. PubMed ID: 16421755
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.
    Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T
    Eur J Surg Oncol; 2005 Oct; 31(8):882-90. PubMed ID: 15993031
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Regulatory T cells and their prognostic value in hepatopancreatobiliary tumours.
    Ozgur HH; Ercetin AP; Eliyatkin N; Seren A; Kupelioglu A; Ortac R; Diniz G; Aktas S
    Hepatogastroenterology; 2014 Oct; 61(135):1847-51. PubMed ID: 25713876
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chemokine receptors support infiltration of lymphocyte subpopulations in human hepatocellular carcinoma.
    Liu Y; Poon RT; Hughes J; Feng X; Yu WC; Fan ST
    Clin Immunol; 2005 Feb; 114(2):174-82. PubMed ID: 15639651
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Tumor-infiltrating FoxP3+ Tregs are associated with CD34 expression and prognosis of hepatocellular carcinoma].
    Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; DU Z
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):25-9. PubMed ID: 22464702
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma.
    Hokuto D; Sho M; Yamato I; Yasuda S; Obara S; Nomi T; Nakajima Y
    Eur J Cancer; 2015 Jan; 51(2):157-65. PubMed ID: 25468715
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma.
    Yao Q; Bao X; Xue R; Liu H; Liu H; Li J; Dong J; Duan Z; Ren M; Zhao J; Song Q; Yu H; Zhu Y; Lu J; Meng Q
    Medicine (Baltimore); 2017 Apr; 96(17):e6735. PubMed ID: 28445292
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma.
    Cheng Y; Gunasegaran B; Singh HD; Dutertre CA; Loh CY; Lim JQ; Crawford JC; Lee HK; Zhang X; Lee B; Becht E; Lim WJ; Yeong J; Chan CY; Chung A; Goh BKP; Chow PKH; Chan JKY; Ginhoux F; Tai D; Chen J; Lim SG; Zhai W; Choo SP; Newell EW
    Immunity; 2021 Aug; 54(8):1825-1840.e7. PubMed ID: 34270940
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunologic cellular characteristics of the tumour microenvironment of hepatocellular carcinoma drive patient outcomes.
    Atanasov G; Dino K; Schierle K; Dietel C; Aust G; Pratschke J; Seehofer D; Schmelzle M; Hau HM
    World J Surg Oncol; 2019 Jun; 17(1):97. PubMed ID: 31170995
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer.
    Lee HE; Chae SW; Lee YJ; Kim MA; Lee HS; Lee BL; Kim WH
    Br J Cancer; 2008 Nov; 99(10):1704-11. PubMed ID: 18941457
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma.
    Garnelo M; Tan A; Her Z; Yeong J; Lim CJ; Chen J; Lim KH; Weber A; Chow P; Chung A; Ooi LL; Toh HC; Heikenwalder M; Ng IO; Nardin A; Chen Q; Abastado JP; Chew V
    Gut; 2017 Feb; 66(2):342-351. PubMed ID: 26669617
    [TBL] [Abstract][Full Text] [Related]  

  • 79. VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.
    Zhang M; Pang HJ; Zhao W; Li YF; Yan LX; Dong ZY; He XF
    BMC Cancer; 2018 May; 18(1):511. PubMed ID: 29720116
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients.
    Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Cai XY; He HW; Jin JJ; Cheng YF; Fan J; Sun J; Qiu SJ
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1555-64. PubMed ID: 23517245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.